EBS
Price
$6.99
Change
-$0.12 (-1.69%)
Updated
Jul 3 closing price
Capitalization
120.07M
37 days until earnings call
INDV
Price
$15.41
Change
+$0.01 (+0.06%)
Updated
Jul 3 closing price
Capitalization
2.91B
18 days until earnings call
Interact to see
Advertisement

EBS vs INDV

Header iconEBS vs INDV Comparison
Open Charts EBS vs INDVBanner chart's image
Emergent Biosolutions
Price$6.99
Change-$0.12 (-1.69%)
Volume$917.38K
Capitalization120.07M
Indivior
Price$15.41
Change+$0.01 (+0.06%)
Volume$2.98M
Capitalization2.91B
EBS vs INDV Comparison Chart in %
Loading...
EBS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INDV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EBS vs. INDV commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EBS is a Hold and INDV is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (EBS: $6.99 vs. INDV: $15.41)
Brand notoriety: EBS and INDV are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: EBS: 72% vs. INDV: 203%
Market capitalization -- EBS: $120.07M vs. INDV: $2.91B
EBS [@Pharmaceuticals: Other] is valued at $120.07M. INDV’s [@Pharmaceuticals: Other] market capitalization is $2.91B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EBS’s FA Score shows that 1 FA rating(s) are green whileINDV’s FA Score has 0 green FA rating(s).

  • EBS’s FA Score: 1 green, 4 red.
  • INDV’s FA Score: 0 green, 5 red.
According to our system of comparison, EBS is a better buy in the long-term than INDV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EBS’s TA Score shows that 4 TA indicator(s) are bullish while INDV’s TA Score has 5 bullish TA indicator(s).

  • EBS’s TA Score: 4 bullish, 3 bearish.
  • INDV’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, EBS is a better buy in the short-term than INDV.

Price Growth

EBS (@Pharmaceuticals: Other) experienced а +2.34% price change this week, while INDV (@Pharmaceuticals: Other) price change was +12.56% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.02%. For the same industry, the average monthly price growth was +2.94%, and the average quarterly price growth was +92.60%.

Reported Earning Dates

EBS is expected to report earnings on Aug 12, 2025.

INDV is expected to report earnings on Jul 24, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.02% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INDV($2.91B) has a higher market cap than EBS($120M). INDV has higher P/E ratio than EBS: INDV (2102.00) vs EBS (17.73). INDV YTD gains are higher at: 23.974 vs. EBS (-26.883). INDV has higher annual earnings (EBITDA): 66M vs. EBS (-518.2M). INDV has more cash in the bank: 410M vs. EBS (112M). INDV has less debt than EBS: INDV (282M) vs EBS (860M). INDV has higher revenues than EBS: INDV (1.09B) vs EBS (1.02B).
EBSINDVEBS / INDV
Capitalization120M2.91B4%
EBITDA-518.2M66M-785%
Gain YTD-26.88323.974-112%
P/E Ratio17.732102.001%
Revenue1.02B1.09B94%
Total Cash112M410M27%
Total Debt860M282M305%
FUNDAMENTALS RATINGS
EBS vs INDV: Fundamental Ratings
EBS
INDV
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
100
Overvalued
PROFIT vs RISK RATING
1..100
10056
SMR RATING
1..100
9477
PRICE GROWTH RATING
1..100
4839
P/E GROWTH RATING
1..100
1199
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EBS's Valuation (57) in the Biotechnology industry is somewhat better than the same rating for INDV (100) in the null industry. This means that EBS’s stock grew somewhat faster than INDV’s over the last 12 months.

INDV's Profit vs Risk Rating (56) in the null industry is somewhat better than the same rating for EBS (100) in the Biotechnology industry. This means that INDV’s stock grew somewhat faster than EBS’s over the last 12 months.

INDV's SMR Rating (77) in the null industry is in the same range as EBS (94) in the Biotechnology industry. This means that INDV’s stock grew similarly to EBS’s over the last 12 months.

INDV's Price Growth Rating (39) in the null industry is in the same range as EBS (48) in the Biotechnology industry. This means that INDV’s stock grew similarly to EBS’s over the last 12 months.

EBS's P/E Growth Rating (11) in the Biotechnology industry is significantly better than the same rating for INDV (99) in the null industry. This means that EBS’s stock grew significantly faster than INDV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EBSINDV
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
66%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
63%
Momentum
ODDS (%)
Bullish Trend 4 days ago
68%
Bullish Trend 4 days ago
62%
MACD
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
76%
Advances
ODDS (%)
Bullish Trend 5 days ago
76%
Bullish Trend 4 days ago
71%
Declines
ODDS (%)
Bearish Trend 20 days ago
89%
Bearish Trend 11 days ago
74%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
73%
Bearish Trend 4 days ago
74%
Aroon
ODDS (%)
Bullish Trend 7 days ago
78%
Bullish Trend 4 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
EBS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INDV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OSBK40.00N/A
N/A
Oconee Financial Corp.
SINGF5.24N/A
N/A
Singapore Airlines Ltd.
VBIZF0.20N/A
N/A
Viva Biotech Holdings
LABFF90.61N/A
N/A
LABORATORIOS FARMACEUTICOS ROVI SA
PORTU10.75N/A
N/A
Southport Acquisition Corporation

EBS and

Correlation & Price change

A.I.dvisor indicates that over the last year, EBS has been loosely correlated with AMRX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if EBS jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EBS
1D Price
Change %
EBS100%
-1.69%
AMRX - EBS
40%
Loosely correlated
+0.60%
HROW - EBS
40%
Loosely correlated
+3.86%
HKMPF - EBS
34%
Loosely correlated
N/A
SIGA - EBS
34%
Loosely correlated
N/A
VTRS - EBS
33%
Poorly correlated
-0.21%
More

INDV and

Correlation & Price change

A.I.dvisor tells us that INDV and EBS have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INDV and EBS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INDV
1D Price
Change %
INDV100%
+0.06%
EBS - INDV
28%
Poorly correlated
-1.69%
COLL - INDV
23%
Poorly correlated
-0.52%
ELAN - INDV
23%
Poorly correlated
-0.54%
ALKS - INDV
21%
Poorly correlated
-0.52%
OPTN - INDV
21%
Poorly correlated
N/A
More